GoodRx Holdings, Inc. (GDRX)

Market Cap	846.69M -49.2%
Revenue (ttm)	787.89M -1.2%
Net Income	20.56M -27.7%
EPS	0.06 -16.7%
Shares Out	338.68M
PE Ratio	42.16
Forward PE	22.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,720,184
Open	2.440
Previous Close	2.430
Day's Range	2.415 - 2.575
52-Week Range	1.770 - 5.810
Beta	1.55
Analysts	Hold
Price Target	3.18 (+27.2%)
Earnings Date	May 6, 2026

About GDRX

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In ad...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Sep 23, 2020
• Employees: 697
• Stock Exchange: NASDAQ
• Ticker Symbol: GDRX
• Website: https://www.goodrx.com

Financial Performance

In 2025, GoodRx Holdings's revenue was $796.85 million, an increase of 0.57% compared to the previous year's $792.32 million. Earnings were $30.44 million, an increase of 85.72%.

Analyst Summary

According to 15 analysts, the average rating for GDRX stock is "Hold." The 12-month stock price target is $3.18, which is an increase of 27.20% from the latest price.

Price Target

$3.18

(27.20% upside)

Analyst Consensus: Hold